Synosia Therapeutics Provides Data From SYN-115 Phase 2a Trial
The data demonstrates that SYN-115 improves measures of motor and non-motor function in patients either alone or in combination with levodopa. The results clearly illustrate the value of

The data demonstrates that SYN-115 improves measures of motor and non-motor function in patients either alone or in combination with levodopa. The results clearly illustrate the value of

Proxeon’s nanoflow liquid chromatography system EASY-nLC has been adopted by a number of proteomic centers for its simplicity and ease of use. It features an intuitive graphical user

Idenix Pharmaceuticals said that the positive pharmacokinetic profile defined in preclinical studies was confirmed by interim Phase I clinical data in healthy volunteers. Additional data presented demonstrated that

Cefprozil (Cefzil) is a cephalosporin antibiotic. It treats many kinds of infections, including those of the respiratory tract, skin, ears. Cefprozil is the generic equivalent of Canadian reference

Cladribine is a small molecule that may interfere with the behavior and the proliferation of certain white blood cells, particularly lymphocytes, which are thought to be involved in

Panobacumab, a fully human IgM monoclonal antibody, is an immunotherapy for these life-threatening infections, and this clinical trial reveals its potential as a more effective treatment than standard

The IMAGE study is a multicenter, randomized clinical trial of 602 heart transplant patients comparing XDx’s AlloMap Molecular Expression Testing, a noninvasive rejection surveillance method utilizing gene expression

BASF SE is is said to be considered the leading potential bidder, reported Dow Jones Newswires quoting some sources familiar with the news. According to Charles Cooley, CFO

Atlas Operations is conducting a voluntary recall after being informed by the FDA that lab analyses found that the products to contain Sulfoaildenafil, an analogue of Sildenafil, an

The researchers used data on screening urine dipsticks from 8,954 healthy school children ages 8 to 15. Of that number, 1,264 children or 14.2% had abnormal results, at